Ophthalmic Disease Therapeutics Market Size, Share and Industry Analysis By Disease Indication (Glaucoma, Retinal Diseases, Dry Eye Disease, Allergy & Infections), By Drug Class (Anti-inflammatory, Anti-infectives, Anti-VEGF, Anti-glaucoma), By Dosage Form (Solid, Liquid, Semi-solid), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Regional Forecast 2019-2026
Market Segmentation:
To get information on various segments, share your queries with us
|
SEGMENTATION |
DETAILS |
|
By Disease Indication |
· Glaucoma · Open Angle Glaucoma · Angle Closure Glaucoma · Others · Retinal Diseases · Diabetic Macular Edema · Macular degeneration · Diabetic Retinopathy · Retinal Vein Occlusion · Others · Dry Eye Disease · Allergy & Infections · Others |
|
By Drug Class |
· Anti-inflammatory · Anti-infectives · Anti-VEGF · Anti-glaucoma · Beta Blockers · Prostaglandins · Alpha Adrenergic Agonists · Carbonic Anhydrase Inhibitors · Combination Drugs · Others |
|
By Dosage Form |
· Solid · Liquid · Semi-solid |
|
By Distribution Channel |
· Hospital Pharmacy · Retail Pharmacy · Online Pharmacy |
|
By Geography |
· North America (USA and Canada) · Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific) · Latin America (Brazil, Mexico, Rest of Latin America) · Middle East & Africa (GCC, South Africa, Rest of the Middle East & Africa) |
- Jun, 2019
- 2018
- 2015-2017
- 156
Healthcare Clients
Related Reports
